Cytokine evaluation in @entity1575 and XXXX .

@entity1 @entity650 @entity39 @entity5 @entity310 @entity8923 @entity160 @entity1575 @entity157
BACKGROUND/AIMS: The purpose of this study was to examine the roles of @entity5 @entity39 factor-alpha ( @entity310 ), @entity650 , @entity8923 , and @entity160 ( @entity160 ) in @entity1 with @entity1575 ( @entity1575 ) and @entity157 ( @entity157 ). METHODOLOGY: @entity160 and cytokine serum concentrations were determined via EIA or ELISA. RESULTS: In total, 81 @entity1 were included, including 9 healthy controls, 36 @entity1575 @entity1 , and 36 @entity157 @entity1 . Significant differences in @entity160 , @entity310 , @entity650 , and @entity8923 between the three groups were noted (p < 0.001). @entity160 was lowest in the healthy subjects, intermediate in @entity1575 @entity1 and highest in @entity157 @entity1 (all p < 0.001). 11-6 and 11-18 concentrations were significantly higher in the @entity157 group than the other two groups. @entity157 and @entity1575 @entity1 with @entity160 concentration > 7ng/ml had increased @entity8923 concentrations compared to both the other groups p < 0.001). In contrast to previously published studies, @entity310 was highest in the healthy group, intermediate in the @entity157 group, and lowest in the @entity1575 group (p < 0.001). CONCLUSIONS: @entity8923 may be a potential @entity5 marker in combination with @entity650 and @entity160 in the diagnosis of @entity157 , but further research including a larger population of @entity1 is essential. Further research is warranted.
